Breast cancers high cyclin cyclin a. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Axilla Cell Line Cell Nucleus Lymph Nodes Epithelial Cells Nipples Neoplastic Stem Cells Mammary Glands, Animal HeLa Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases35

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Invasiveness Neoplasm Metastasis Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Carcinoma Genetic Predisposition to Disease Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Ovarian Neoplasms Lymphatic Metastasis Neoplasm Recurrence, Local Lung Neoplasms Neoplasms Disease Progression Prostatic Neoplasms Fibrocystic Breast Disease Cell Transformation, Neoplastic Colonic Neoplasms Bone Neoplasms Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Adenocarcinoma Neoplasms, Second Primary Triple Negative Breast Neoplasms Pancreatic Neoplasms Inflammatory Breast Neoplasms Carcinoma, Squamous Cell Neovascularization, Pathologic Uterine Cervical Neoplasms Fibroadenoma

Chemicals and Drugs83

Cyclin E Cyclin D1 Cyclin A Cyclin B Cyclin B1 Cyclin D2 Cyclin A1 Cyclin D3 Cyclin A2 Cyclin D Cyclins Cyclin G1 Cyclin G Receptors, Estrogen Cyclin C Cyclin-Dependent Kinases Receptor, erbB-2 Cyclin B2 Tamoxifen Receptors, Progesterone Cyclin T Cyclin-Dependent Kinase 2 Cyclin G2 Tumor Markers, Biological Cyclin H Cyclin-Dependent Kinase 4 CDC2-CDC28 Kinases Neoplasm Proteins Antineoplastic Agents Antineoplastic Agents, Hormonal Cell Cycle Proteins RNA, Messenger CDC2 Protein Kinase Cyclin-Dependent Kinase Inhibitor p27 Retinoblastoma Protein Estrogen Receptor alpha Estrogens Protein-Serine-Threonine Kinases Tumor Suppressor Proteins RNA, Small Interfering Oncogene Proteins Tumor Suppressor Protein p53 Cyclin I BRCA2 Protein Estrogen Antagonists BRCA1 Protein Cyclin-Dependent Kinase Inhibitor p21 Aromatase Inhibitors DNA, Neoplasm Transcription Factors Ki-67 Antigen Estradiol Proto-Oncogene Proteins DNA-Binding Proteins Cyclin-Dependent Kinase 6 Estrogen Receptor Modulators Fluorouracil Nuclear Proteins Nitriles Antibodies, Monoclonal, Humanized Cyclophosphamide Selective Estrogen Receptor Modulators Antibodies, Monoclonal Epirubicin RNA, Neoplasm Receptor, Epidermal Growth Factor Enzyme Inhibitors Anticarcinogenic Agents Paclitaxel DNA Primers Proto-Oncogene Proteins c-akt Antigens, Neoplasm Microtubule-Associated Proteins Cancer Vaccines Antibiotics, Antineoplastic MicroRNAs Triazoles Proto-Oncogene Proteins c-myc Antigens, CD24 Proliferating Cell Nuclear Antigen Mucin-1 beta Catenin E2F Transcription Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Prognosis Mammography Neoplasm Staging Immunohistochemistry Early Detection of Cancer Mastectomy Risk Factors Chemotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Blotting, Western Mammary Neoplasms, Experimental Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Disease-Free Survival Breast Self-Examination Risk Follow-Up Studies Survival Rate Transfection Prospective Studies Risk Assessment Retrospective Studies Xenograft Model Antitumor Assays Mastectomy, Segmental Odds Ratio Treatment Outcome Incidence Oligonucleotide Array Sequence Analysis Multivariate Analysis Cohort Studies Transplantation, Heterologous Neoplasm Transplantation Tissue Array Analysis Registries Sensitivity and Specificity Ultrasonography, Mammary Polymerase Chain Reaction Immunoenzyme Techniques Tumor Burden Predictive Value of Tests Kaplan-Meier Estimate Models, Biological SEER Program Questionnaires Logistic Models Combined Modality Therapy Breast Implants Flow Cytometry Gene Knockdown Techniques Reproducibility of Results Neoplasm Grading In Situ Hybridization, Fluorescence Mass Screening Radiotherapy, Adjuvant Mammaplasty Confidence Intervals Drug Screening Assays, Antitumor Clinical Trials as Topic Immunoblotting Neoadjuvant Therapy Proportional Hazards Models Molecular Targeted Therapy Genetic Testing

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Cell Cycle Cell Proliferation G1 Phase Genes, BRCA1 Cell Division Postmenopause S Phase Phosphorylation Drug Resistance, Neoplasm Genetic Predisposition to Disease Apoptosis Breast Feeding Signal Transduction Premenopause Mutation Down-Regulation Risk Menopause Promoter Regions, Genetic Time Factors Transfection Mitosis Genes, BRCA2 Genes, erbB-2 Genes, bcl-1 Odds Ratio Base Sequence RNA Interference Up-Regulation Cell Movement Gene Expression G2 Phase Cell Growth Processes Transcription, Genetic Sensitivity and Specificity Gene Amplification Genotype Protein Binding Dose-Response Relationship, Drug Germ-Line Mutation Polymorphism, Genetic DNA Methylation Cell Survival Phenotype Gene Silencing Enzyme Activation Genes, Tumor Suppressor Amino Acid Sequence Parity Gene Expression Regulation Genes, p53

Disciplines and Occupations1

Immunohistochemistry

Information Science8

Survival Rate Molecular Sequence Data Incidence Base Sequence Registries SEER Program Questionnaires Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Risk Follow-Up Studies Survival Rate Prospective Studies Risk Assessment Retrospective Studies Age Factors Odds Ratio Treatment Outcome Incidence Multivariate Analysis Cohort Studies Registries Sensitivity and Specificity Predictive Value of Tests Kaplan-Meier Estimate SEER Program Questionnaires Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Clinical Trials as Topic Parity Proportional Hazards Models Genetic Testing

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Cyclin E Cyclin D1 Cyclin A Cyclin B Breast Breast Neoplasms Cyclin B1 Cyclin D2 Cyclin A1 Cyclin D3 Prognosis Cyclin A2 Cyclin D Cyclins Carcinoma, Ductal, Breast Cyclin G1 Cyclin G Cell Line, Tumor Receptors, Estrogen Cyclin C Gene Expression Regulation, Neoplastic Cyclin-Dependent Kinases Receptor, erbB-2 Cell Cycle Cyclin B2 Breast Diseases Tamoxifen Receptors, Progesterone Cyclin T Cyclin-Dependent Kinase 2 Mammography Neoplasm Invasiveness Neoplasm Metastasis Cyclin G2 Tumor Markers, Biological Cyclin H Cyclin-Dependent Kinase 4 Cell Proliferation CDC2-CDC28 Kinases Neoplasm Proteins Tumor Cells, Cultured Breast Neoplasms, Male Antineoplastic Agents Antineoplastic Agents, Hormonal G1 Phase Neoplasm Staging Cell Cycle Proteins Immunohistochemistry RNA, Messenger Early Detection of Cancer Mastectomy CDC2 Protein Kinase Genes, BRCA1 Risk Factors Cell Division Mice, Nude Postmenopause Carcinoma, Lobular Chemotherapy, Adjuvant Cyclin-Dependent Kinase Inhibitor p27 MCF-7 Cells Reverse Transcriptase Polymerase Chain Reaction S Phase Phosphorylation Retinoblastoma Protein Drug Resistance, Neoplasm Carcinoma, Intraductal, Noninfiltrating Estrogen Receptor alpha Survival Analysis Blotting, Western Carcinoma Genetic Predisposition to Disease Estrogens Mammary Neoplasms, Experimental Gene Expression Profiling Protein-Serine-Threonine Kinases Apoptosis Antineoplastic Combined Chemotherapy Protocols Breast Feeding Case-Control Studies Signal Transduction Tumor Suppressor Proteins Premenopause Neoplasms, Hormone-Dependent Disease-Free Survival Mutation Ovarian Neoplasms Lymphatic Metastasis Breast Self-Examination RNA, Small Interfering Down-Regulation Oncogene Proteins Risk Follow-Up Studies Neoplasm Recurrence, Local Survival Rate Lung Neoplasms Tumor Suppressor Protein p53 Cyclin I BRCA2 Protein

No FAQ available that match "breast cancers high cyclin cyclin a"